期刊文献+

表达分泌型脑源性神经营养因子的腺相关病毒载体的构建及其表达的检测 被引量:3

Construction and Expression of Recombinant Adeno-Associated Virus Expressing Brain-Derived Neurotrophic Factor
下载PDF
导出
摘要 采用PCR和体外连接的方法构建了带有信号肽的脑源性神经营养因子(BDNF)的融合基因,将此基因插入到腺相关病毒载体穿梭质粒pSNAV,然后用重组质粒pSNAV-Ig-BDNF转染包装细胞,筛选出永久细胞株后,用携带腺相关病毒rep及cap基因的单纯疱疹病毒超感染包装细胞,成功包装出含有目的基因的一型血清型腺相关病毒。经PCR鉴定该病毒含有目的基因片段,被该病毒感染的细胞裂解液经Western blotting证实有BDNF表达,其培养液经ELISA检测证实含有高水平的BDNF蛋白。该病毒与小量的非复制型腺病毒Ad-null联合应用时,其BDNF蛋白的表达水平显著提高。可弥补腺相关病毒起效慢、对细胞转导效率低的弱点,为今后应用AAV作基因治疗提供了实验证据。 A fusion gene called Ig-BDNF, in which brain-derived neurotrophic factor cDNA fused to the 3' end of signal peptide of Ig coding sequence, was constructed by PCR, digested and subcloned into shuttle plasmid pSNAV to obtain a recombinant plasmid pSNAV-Ig-BDNF. Then the plasmid encoding fusion protein was transfected into 293 cell lines and the stably transfected clones were selected with neomycin. AAV1 containing Ig-BDNF fusion gene vectors were obtained by super-infection by Herpes virus. The resultant adeno-associated virus vectors AAV-Ig-BDNF were confirmed by PCR, Western blotting and a sandwich enzyme-linked immunosorbent assay. (ELISA) after infection of 293 cell lines. The results indicated that AAV-Ig-BDNF contained the target gene, and infected cells and produced the fusion protein into the supernatant. The content of BDNF in medium per 5×10^4 cells over a 24 h incubation period reached 1000 pg/mL. With the help of non-replicative adenovirus during AAV-Ig-BDNF infection, the expression of BDNF increased 7-8 fold, and the enhancement of BDNF gene expression was observed in a concentration-dependent manner. These results suggested that a functional AAV-Ig-BDNF was successfully constructed and it offers basis for further study for gene therapy of neural degeneration diseases .
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第2期328-332,共5页 Chinese Journal of Biotechnology
基金 国家自然科学基金杰出青年项目(No.30428015) ~~国家973项目(No.2004CB518800)~~
关键词 腺相关病毒 脑源性神经营养因子 基因表达 基因治疗 rAAV, BDNF, gene expression, gene therapy
  • 相关文献

参考文献13

  • 1During MJ, Leone P. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders. Clin Neurosci, 1995-1996, 3(5): 292-300.
  • 2Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Ther, 1995, 2(6): 357-362.
  • 3Bueler H. Adeno-associated viral vectors for gene transfer and gene therapy. Biol Chem, 1999, 380(6): 613-622.
  • 4Lai CM, Lai YK, Rakoczy PE. Adenovirus and adenoassociated virus vectors. DNA Cell Biol, 2002, 21(12): 895-913.
  • 5Goncalves MA. Adeno-associated virus: from defective virus to effective vector. Virol J, 2005, 2: 43.
  • 6Li C, Bowles DE, van Dyke T, et al. Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther, 2005, 12(12): 913-925.
  • 7Obata K, Noguchi K. BDNF in sensory neurons and chronic pain. Neurosci Res, 2006, 55(1): 1-10.
  • 8Chao MV, Rajagopal R, Lee FS. Neurotrophin signaling in health and disease. Clin Sci(Lond), 2006, 110(2): 167-173.
  • 9Moller JC, Kruttgen A, Heymach VJ Jr, et al. Subcellular localization of epitope-tagged neurotrophins in neuroen-docrine cells. Journal of Neuroscience Research, 1998, 51(4): 463-472.
  • 10Srivastava A. Parvovirus-based vectors for human gene therapy. Blood Cells, 1994, 20(2-3): 531-538.

同被引文献16

  • 1井申荣,邹全明.白细胞介素10的研究进展[J].免疫学杂志,2006,22(z1):26-28. 被引量:16
  • 2Lu, Sen,Yu, Yue,Gao, Yun,Li, Guo-Qiang,Wang, Xue-Hao.Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):258-263. 被引量:10
  • 3张峰,霍金龙,曾养志.基因治疗的应用及研究进展[J].生物技术通讯,2007,18(4):677-679. 被引量:6
  • 4Pike SE, Yao L, Jones KD, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med, 1998, 188(12): 2349-2356.
  • 5Pike SE, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood, 1999, 94(7): 2461-2468.
  • 6I Xiao F, Wei Y, Yang L, et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther, 2002, 9(18): 1207-1213.
  • 7Li L, Yuan YZ, Lu J, et al. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice. Gut, 2006, 55(2): 259-265.
  • 8Liu MH, Imam H, Oberg K, et al. Gene transfer of Vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior. Neuroendocrinology, 2005, 82(1): 1-10.
  • 9Okada F, Rakj J, Croix BT, et al. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factoryvascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA, 1998, 95(7): 3609-3614.
  • 10关翔宇,孔军伶,绍长玲.基因治疗载体的研究进展[J].检验医学教育,2007,14(2):41-43. 被引量:3

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部